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Introduction
Hearing loss (HL) is a sensory impairment that affects mil-
lions of people worldwide, with the probability of approxi-
mately 1 in 1000 live births (http://hearing.screening.nhs.uk/
nationalprog). Approximately, two-third of individuals with 
hearing impairment reside in developing countries, wherein 
more than 60% cases are attributed to genetic factors [1]. The 
genetic forms of HL are syndromic, which is accompanied by 
other specific abnormalities, and non-syndromic HL (NSHL), 
in which no additional abnormalities are observed. Autoso-
mal recessive mode of inheritance (ARNSHL) comprises 
80% of NSHL cases. ARNSHL is highly heterogeneous, with 
over 100 associated loci and >60 identified causative genes 
(http://hereditaryhearingloss.org/). GJB2 at the DFNB1 locus 
is responsible for 60% of all deafness cases, and over 100 
GJB2 pathogenic variants have been reported with variable 
frequency among disparate world populations [2-11]. 
c.35delG accounts for >50% of GJB2-related NSHL in many 
western populations [12]. Other mutations are more origin 
specific. In the Japanese population, 235delC is more preva-
lent [3] and c.167delT is common in Ashkenazi Jews [2]. In 
individuals of Indian and Pakistani ancestry, c.71G>A is the 
common GJB2 variant [3]. Over the last decade, several stud-
ies have been conducted on the Iranian population to identify 
the mutation spectrum and prevalence of GJB2 mutations 
[13-23]. The different ethnicities coupled with the high fre-
quency of familial marriages (38% on an average) [24] tend 
to change mutation frequencies among the ethnic groups 
[25]. Therefore, for accurate genetic counseling, studying 
certain ethnic groups is of high importance. In this study, we 
have summarized the published data on the frequency and 
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Diagnosis of pre-lingual hearing loss (HL) is difficult owing to the high number of genes re-
sponsible. The most frequent cause of HL is DFNB1 due to mutations in the GJB2 gene. It 
represents up to 40% of HL cases in some populations. In Iran, it has previously been 
shown that DFNB1 accounts for 16-18% of cases but varies among different ethnic groups. 
Here, we reviewed results from our three previous publications and data from other published 
mutation reports to provide a comprehensive collection of data for GJB2 mutations and HL 
in northern Iran. In total, 903 unrelated families from six different provinces, viz., Gilan, Ma-
zandaran, Golestan, Ghazvin, Semnan, and Tehran, were included and analyzed for the type 
and prevalence of GJB2 mutations. A total of 23 different genetic variants were detected from 
which 18 GJB2 mutations were identified. GJB2 mutations were 20.7% in the studied north-
ern provinces, which was significantly higher than that reported in southern populations of 
Iran. Moreover, a gradient in the frequency of GJB2 mutations from north to south Iran was 
observed. c.35delG was the most common mutation, accounting for 58.4% of the cases 
studied. This study suggests that c.35delG mutation in GJB2 is the most important cause of 
HL in northern Iran. J Audiol Otol 2019;23(4):175-180
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profile of GJB2 mutations in 903 unrelated families from six 
different provinces, viz., Gilan, Mazandaran, Golestan, Ghaz-
vin, Semnan, and Tehran, in north Iran compared to those in 
other parts of the country.
Methods
This study included results from our three previous pub-
lications on GJB2-related HL in Iran [19-36]. We also per-
formed a PubMed, Web of Science, and Google Scholar search 
using the search terms “GJB2 mutations”, “connexin 26”, 
and “Iran”. In the search results, we limited the search to hu-
mans with available information on molecular genetics of HL. 
Studies were included when the following three criteria were 
fulfilled: 1) inclusion of NSHL subjects, 2) known ethnicity of 
the tested subjects, and 3) detection of all GJB2 variants. 
Studies were excluded if HL was a result of environmental 
factors, such as infection, trauma, rubella, meningitis, mumps, 
ototoxic drugs, and premature birth. Research data, including 
data of 903 unrelated deaf families, from the north provinces 
were collected. The frequency and mutation type of 903 deaf 
families were extracted from relevant studies and categorized 
corresponding to the geographical boundaries. In silico anal-
yses were also performed using the available software tools 
(Mutation Taster and SIFT; http://www.mutationtaster.org, 
https://sift.bii.a-star.edu.sg/) to predict the pathogenicity of 
the mutations.
Results
Data from 903 unrelated families from six provinces were 
analyzed (Table 1). The groups studied consisted of 429 fami-
lies from Tehran (47.5%), 156 families from Gilan (17.3%), 
111 families from Semnan (12.3%), 100 families from Ma-
zandaran (11.1%), 85 families from Golestan (9.4%), and 22 
families from Ghazvin (2.4%). Among these families, 66.5% 
reported parental consanguinity, whereas close consanguinity 
was denied in 33.5% cases (Table 2). GJB2 mutation allele 
frequencies of each studied group were 32%, 31.3%, 20.9%, 
19.75%, 11.5%, and 9% in the total studied families (n=903) 
of Mazandaran, Gilan, Golestan, Tehran, Semnan, and Ghaz-
vin, respectively (Fig. 1). When moving from the west to east 
and north to south of the studied provinces, a gradual de-
crease in GJB2 HL was observed.
In total, 30 different variants were identified, 22 of which 
were reported as pathogenic. These included c.-23+1G>A, 
c.35delG, c.71G>A, c.95G>A, c.136G>A, c.139G>T, 
c.167delT, c.224G>A, c.229T>C, c.230G>A, c.235delC, 
K102Q, c.313-326del, c.327-328delGG, c.358-360delGAG, 
c.326G>A, c.334-36delAA, c.427C>T, 463-464delTA, c. 
487A>G, c.511G>A, and c.551G>C. The allele variants 
identified in various Iranian ARSNSHL families are summa-
rized in Table 3. In the studied populations, c.35delG was the 
most frequent mutation, accounting for 58.4% cases in the 
populations studied. The highest rate of c.35delG mutation 
was detected in the Gilan province with an allele frequency of 
27.6%, whereas this rate was 6.3% in Semnan (Table 1). A 
Table 1. Characteristics of included studies
Number First author Year Province Detection method Case Hearing loss type Reference
1 Chaleshtori 2002 Gilan ARMS-PCR and sanger sequencing   87 ARNSHL [35]
2 Bazazzadegan 2012 Gilan Sanger sequencing   69 NSHL [30]
3 Bazazzadegan 2012 Ghazvin Sanger sequencing   22 NSHL [30]
4 Hosseinipour 2005 Golestan ARMS-PCR and sanger sequencing   55 ARNSHL [19]
5 Bazazzadegan 2012 Golestan Sanger sequencing   30 NSHL [30]
6 Bazazzadegan 2012 Tehran Sanger sequencing 173 NSHL [30]
7 Chaleshtori 2005 Tehran ARMS-PCR and sanger sequencing 256 ARNSHL [36]
8 Chaleshtori 2007 Semnan Sanger sequencing 111 NSHL [27]
9 Bazazzadegan 2012 Mazandaran Sanger sequencing 100 NSHL [30]
ARMS-PCR: amplification-refractory mutation system PCR, ARNSHL: autosomal recessive non-syndromic hearing loss, NSHL: non-
syndromic hearing loss
Table 2. The frequency of consanguinity among different provinces of north Iran
Province Gilan Mazandaran Golestan Tehran Semnan Ghazvin
Consanguinity 85 57 58 307 76 18
Non-consanguinity 71 43 27 122 35 4
Total* 156 100 85 429 111 22
*Total case number
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specific combination of GJB2 mutation types and frequencies 
were observed in the different studied provinces (Table 3). A 
higher GJB2 mutation diversity (17 types) was identified in 
Tehran, whereas the lowest diversity was observed in Ghaz-
vin (two types). 
Discussion
In this study, we reviewed the prevalence and type of GJB2 
mutations in 903 deaf families from six provinces in north-
ern Iran. GJB2 mutations accounted for 20.7% of HL cases. 
The genetic epidemiology of HL is very different in a country 
even in neighboring provinces because of subtle variations in 
their ethnic composition and founder effects [26]. The Irani-
an population is composed of many different ethnic groups; 
therefore, it is significant to discuss ethnicity-specific data. 
Accepting the northwest to southeast GJB2 HL gradient 
throughout Iran, our data showed a north to south gradient 
among Iranian populations with a GJB2 mutations frequency 
of 32% in Mazandaran and 9% in Ghazvin. A study performed 
by Chaleshtori, et al. [27] on 890 ARNSHL families showed 
that GJB2 mutations account for 14.6% HL cases in the Ira-
nian population, and c.35delG mutation was the most fre-
quent mutation (~75% of the reported GJB2 mutations).
Our results showed that the contribution of GJB2 mutations 
to ARNSHL was 32% in Mazandaran (north Iran), which is 
similar to the data from the Azer Turkish population in north-
west Iran [28]. Bonyadi, et al. [28] screened 209 HL families 
from the Azerbijan and Ardebil provinces in northwest Iran 
for GJB2 mutations. They reported that GJB2 mutations were 
detected in 28% of the HL families studied and c.35delG was 
the most prevalent mutation, accounting for 64.5% of muta-
tions, which is similar to the results reported for the Turkish 
population [29].
In the study performed by Bazazzadegan, et al. [30] on 
111 deaf families, GJB2 mutations accounted for 11.5% HL 
cases in the Semnan province, which is approximately one-
third of the frequency of GJB2 mutations in the Mazandaran 
province. In a previous study, we showed that GJB2 mutations 
explain the etiology of HL in 3.7% patients from the Hormoz-
gan province in south of Iran [31]. On the basis of these re-
sults, it can be concluded that the incidence of GJB2 mutations 
decreases gradually in both west to east and north to south di-
rections (Fig. 1), drawing the migration pathway of the initial 
founders.
Another finding of this study was the mutation rate of 
c.35delG in the Gilan province, which was different from that 
of Iranian population regions. Chaleshtori, et al. [27] screened 
87 deaf families from the Gilan province in north Iran for 
DFNB1 mutations and reported that GJB2 mutations were 
found in 27.6% of the deaf families studied. Interestingly, 
c.35delG mutation was identified in 95.9% of GJB2 muta-
tions in the Gilan province, whereas this mutation was absent 
in the Baluchi population (southeast Iran) [32]. According to 
our knowledge, this is the highest rate of c.35delG mutation 
reported from Iran so far. Results obtained for the carrier fre-
quency of c.35delG mutation was 2.8% in the Gilan province, 
whereas it was 1% in the remaining Iranian groups [33]. How-
ever, this population is bounded in the north by the Caspian 
Sea and remains relatively isolated by mountains from other 
parts of Iran.
In our studied populations, the most frequent mutation was 
c.35delG, accounting for 58.4% of GJB2 mutations. c.35delG 
(deletion of guanine in position 30-35; rs80338939) is the 
most common mutation worldwide as well as in many coun-
tries in the Middle East, such as Turkey and north and north-
west Iran [34]. The study of the geographical distribution of 
GJB2 mutations showed more allelic heterogeneity in the 
north compared to that in the south of Iran [31,35,36]. The 
four most frequent mutations of GJB2 in the north of Iran 
were c.35delG, c.71G>A, c.-23+1G>A, and c.551G>C and are 
responsible for ~66.3% of all pathogenic alleles in north Iran 
(Table 3). c.35delG mutation, which is rare among southern 
regions, accounts for 58.4% of GJB2 mutations in the north-
ern populations. c.71G>A, c.-23+1G>A, and c.551G>C are 
the second, third, and fourth common mutations, with an oc-
currence of 2.9%, 2.45%, and 2.45%, respectively, of all 
pathogenic alleles.
칼 라
Fig. 1. The prevalence of GJB2-related mutations in different re-
gions of Iran (south 0-4% [27,44], northwest 22-27% [27,44], 
and central 13-15% [30,44]). Six north provinces (Gilan, Mazan-
daran, Golestan, Ghazvin, Semnan, and Tehran) are shown in the 
map.
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p.Trp24*, a nonsense mutation, is because of c.71G>A tran-
sition, which changes TGG codon for tryptophan residue to a 
stop codon, leading to a truncated protein with probably no 
functional properties. c.71G>A is the most common mutation 
in Slovak Romany, Pakistan, and Indian populations [37-39]. 
The rate of carriers of c.71G>A mutation is 4.08% in the 
Pakistan population [8]. This mutation is observed at a high 
frequency in the Baluchi group (southeast Iran) and accounts 
for 80% of the mutant alleles in this ethnicity, whereas this 
rate was only 2.9% in our study population [40].
p.Arg184Pro, a missense variant, is the result of c.551G>C 
transition, which changes CGC codon for arginine residue to 
a CCC codon for proline, probably leading to a non-function-
al protein. This mutation has been reported in an Australian 
family for the first time [41]. In silico analyses are consistent 
with the pathogenicity of the mutation (Table 3). p.Arg184Pro 
is not the common mutation in Iranian populations, but this 
mutation is observed at a high frequency in north and north-
west Iran because of founder effects [25].
The present data showed a particular combination of GJB2 
mutation diversity in different provinces of north Iran. A high-
er GJB2 mutation diversity (17 types) was identified in the 
Tehran province, showing the co-existence of several differ-
ent ethnic groups and marked immigration to the metropoli-
tan during the last century. In contrast with high diversity in 
Tehran, we found a very low rate of diversity in some popu-
lations, such as Ghazvini who are probably isolated owing to 
cultural and geographical barriers.
Chaleshtori, et al. [27] reported that more than 40% of pa-
tients were heterozygous carriers for GJB2 mutations in the 
Gilan province. Hence, these patients are subjected to analy-
sis to investigate GJB6 mutations [42-44].
Conclusion
The critical and specific position of Iran and the existence 
of various ethnic groups of different cultures suggest high 
heterogeneity throughout Iran, but specific intra-ethnic tradi-
tions, such as intragroup marriages, may result in high ho-
mogeneity in some loci and mutations within groups. GJB2 
mutations are responsible for 20.7% cases of deaf families in 
the north, which is more than that in central Iran (13-15%), 
suggesting the migration pathway from the north to central 
Iran through the silk route. Regarding GJB2 mutations, c.35delG 
was the most common mutation first tested. In the studied 
populations, some mutations were frequent, which were de-
tected in each group, e.g., the frequency of c.35delG muta-
tion showed a high rate in the Gilan province (north Iran) ac-
counting for 90.2% of the mutant alleles studied. In addition, 
the causes of HL in some populations, such as Golestani, are 
likely more homogenous than those in other parts of north 
Iran. The present study will help in improving genetic diag-
nosis, cascade screening, genetic counseling, and molecular 
epidemiology of HL in Irani populations, particularly of north-
ern origin.
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